This notice is for prior information only
Legal Basis:
Directive 2014/24/EU
Section I: Contracting authority
I.1)Name and addresses
Official name: SERVICIO MADRILEÑO DE SALUD - HOSPITAL UNIVERSITARIO 12 DE OCTUBRE
National registration number: Q2877010E
Postal address: AVENIDA DE CORDOBA, SIN NÚMERO
Town: MADRID
NUTS code:
ES300 Madrid
Postal code: 28041
Country: Spain
E-mail:
ucontratacion.hdoc@salud.madrid.org
Telephone: +34 913908552
Fax: +34 913908181
Internet address(es):
Main address:
http://contratos-publicos.comunidad.madrid
I.3)Communication
Additional information can be obtained from the abovementioned address
I.4)Type of the contracting authority
Body governed by public law
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
PLAN ANUAL CONTRATACIÓN 2024 SERVICIOS FARMACEUTICOS
II.1.2)Main CPV code
33696000 Reagents and contrast media
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS ADVANCED ACCELERATOR APPLICATI: LUTECIO (177LU) OXODOTREOTIDA 370 MBQ/ML INYECTABLE PERFUSIÓN 25 ML
II.1.5)Estimated total value
Value excluding VAT: 5 155 488.00 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS ADVANCED ACCELERATOR APPLICATI: LUTECIO (177LU) OXODOTREOTIDA 370 MBQ/ML INYECTABLE PERFUSIÓN 25 ML
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2024
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS TAKEDA FAR.ESPAÑA,S.A: INMUNOGLOBULINA G HUMANA 10 G INYECTABLE PERFUSIÓN SC 100 ML
II.1.2)Main CPV code
33652000 Antineoplastic and immunomodulating agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS TAKEDA FAR.ESPAÑA,S.A: INMUNOGLOBULINA G HUMANA 10 G INYECTABLE PERFUSIÓN SC 100 ML
II.1.5)Estimated total value
Value excluding VAT: 519 480.00 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS TAKEDA FAR.ESPAÑA,S.A: INMUNOGLOBULINA G HUMANA 10 G INYECTABLE PERFUSIÓN SC 100 ML
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2024
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS TAKEDA FAR.ESPAÑA,S.A: INMUNOGLOBULINA G HUMANA 20 G INYECTABLE PERFUSIÓN SC 200 ML
II.1.2)Main CPV code
33652000 Antineoplastic and immunomodulating agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS TAKEDA FAR.ESPAÑA,S.A: INMUNOGLOBULINA G HUMANA 20 G INYECTABLE PERFUSIÓN SC 200 ML
II.1.5)Estimated total value
Value excluding VAT: 894 660.00 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS TAKEDA FAR.ESPAÑA,S.A: INMUNOGLOBULINA G HUMANA 20 G INYECTABLE PERFUSIÓN SC 200 ML
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2024
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS TAKEDA FAR.ESPAÑA,S.A: INMUNOGLOBULINA G HUMANA 30 G INYECTABLE PERFUSIÓN SC 300 ML
II.1.2)Main CPV code
33652000 Antineoplastic and immunomodulating agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS TAKEDA FAR.ESPAÑA,S.A: INMUNOGLOBULINA G HUMANA 30 G INYECTABLE PERFUSIÓN SC 300 ML
II.1.5)Estimated total value
Value excluding VAT: 2 164 500.00 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS TAKEDA FAR.ESPAÑA,S.A: INMUNOGLOBULINA G HUMANA 30 G INYECTABLE PERFUSIÓN SC 300 ML
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2024
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS TAKEDA FAR.ESPAÑA,S.A: INMUNOGLOBULINA G HUMANA 5 G INYECTABLE PERFUSIÓN SC 50 ML
II.1.2)Main CPV code
33652000 Antineoplastic and immunomodulating agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS TAKEDA FAR.ESPAÑA,S.A: INMUNOGLOBULINA G HUMANA 5 G INYECTABLE PERFUSIÓN SC 50 ML
II.1.5)Estimated total value
Value excluding VAT: 223 665.00 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS TAKEDA FAR.ESPAÑA,S.A: INMUNOGLOBULINA G HUMANA 5 G INYECTABLE PERFUSIÓN SC 50 ML
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2024
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS TAKEDA FAR.ESPAÑA,S.A: MARIBAVIR 200MG COMPRIMIDO
II.1.2)Main CPV code
33651400 Antivirals for systemic use
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS TAKEDA FAR.ESPAÑA,S.A: MARIBAVIR 200MG COMPRIMIDO
II.1.5)Estimated total value
Value excluding VAT: 2 059 200.00 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS TAKEDA FAR.ESPAÑA,S.A: MARIBAVIR 200MG COMPRIMIDO
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2024
Section II: Object
II.1)Scope of the procurement
II.1.2)Main CPV code
33651100 Antibacterials for systemic use
II.1.3)Type of contract
Supplies
II.1.4)Short description:
II.1.5)Estimated total value
Value excluding VAT: 2 494 290.77 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2024
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS ASTRAZENECA FARMACEUTICA SPAIN: acalabrutinib 100 mg comprimido
II.1.2)Main CPV code
33652100 Antineoplastic agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS ASTRAZENECA FARMACEUTICA SPAIN: acalabrutinib 100 mg comprimido
II.1.5)Estimated total value
Value excluding VAT: 1 144 392.80 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS ASTRAZENECA FARMACEUTICA SPAIN: acalabrutinib 100 mg comprimido
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2024
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS ASTRAZENECA FARMACEUTICA SPAIN: TEZEPELUMAB 210 MG INYECTABLE 1,91 ML JERINGA PRECARGADA
II.1.2)Main CPV code
33673000 Medicinal products for obstructive airway diseases
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS ASTRAZENECA FARMACEUTICA SPAIN: TEZEPELUMAB 210 MG INYECTABLE 1,91 ML JERINGA PRECARGADA
II.1.5)Estimated total value
Value excluding VAT: 667 624.87 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS ASTRAZENECA FARMACEUTICA SPAIN: TEZEPELUMAB 210 MG INYECTABLE 1,91 ML JERINGA PRECARGADA
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2024
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS NOVARTIS FARMACEUTICA,S.A.: brolucizumab 120 mg/ml inyectable 0,165 ml jeringa precargada
II.1.2)Main CPV code
33662100 Ophthalmologicals
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS NOVARTIS FARMACEUTICA,S.A.: brolucizumab 120 mg/ml inyectable 0,165 ml jeringa precargada
II.1.5)Estimated total value
Value excluding VAT: 185 642.43 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS NOVARTIS FARMACEUTICA,S.A.: brolucizumab 120 mg/ml inyectable 0,165 ml jeringa precargada
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2024
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS NOVARTIS FARMACEUTICA,S.A.: OCTREOTIDA 20 MG INYECTABLE
II.1.2)Main CPV code
33642100 Pituitary, hypothalamic hormones and analogues
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS NOVARTIS FARMACEUTICA,S.A.: OCTREOTIDA 20 MG INYECTABLE
II.1.5)Estimated total value
Value excluding VAT: 209 310.40 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS NOVARTIS FARMACEUTICA,S.A.: OCTREOTIDA 20 MG INYECTABLE
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2024
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS ROCHE FARMA, S.A.: pertuzumab/trastuzumab 1200 mg/600 mg inyectable 15 ml
II.1.2)Main CPV code
33652100 Antineoplastic agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS ROCHE FARMA, S.A.: pertuzumab/trastuzumab 1200 mg/600 mg inyectable 15 ml
II.1.5)Estimated total value
Value excluding VAT: 1 010 100.00 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS ROCHE FARMA, S.A.: pertuzumab/trastuzumab 1200 mg/600 mg inyectable 15 ml
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2024
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS ROCHE FARMA, S.A.: pertuzumab/trastuzumab 600 mg/600 mg inyectable 10 ml
II.1.2)Main CPV code
33652100 Antineoplastic agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS ROCHE FARMA, S.A.: pertuzumab/trastuzumab 600 mg/600 mg inyectable 10 ml
II.1.5)Estimated total value
Value excluding VAT: 3 900 602.16 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS ROCHE FARMA, S.A.: pertuzumab/trastuzumab 600 mg/600 mg inyectable 10 ml
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2024
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS ALBIREO AB: odevixibat 400 microgramos capsula
II.1.2)Main CPV code
33610000 Medicinal products for the alimentary tract and metabolism
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS ALBIREO AB: odevixibat 400 microgramos capsula
II.1.5)Estimated total value
Value excluding VAT: 1 048 176.98 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS ALBIREO AB: odevixibat 400 microgramos capsula
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2024
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS ALNYLAM PHARMACEUTICALS SPAIN, S. L.: vutrisirán 25 mg inyectable 0,5 ml jeringa precargada
II.1.2)Main CPV code
33661700 Other nervous system medicinal products
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS ALNYLAM PHARMACEUTICALS SPAIN, S. L.: vutrisirán 25 mg inyectable 0,5 ml jeringa precargada
II.1.5)Estimated total value
Value excluding VAT: 1 109 434.56 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS ALNYLAM PHARMACEUTICALS SPAIN, S. L.: vutrisirán 25 mg inyectable 0,5 ml jeringa precargada
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2024
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS FERRER FARMA S.A.: CANGRELOR 50 MG INYECTABLE
II.1.2)Main CPV code
33621100 Antithrombotic agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS FERRER FARMA S.A.: CANGRELOR 50 MG INYECTABLE
II.1.5)Estimated total value
Value excluding VAT: 1 515 150.00 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS FERRER FARMA S.A.: CANGRELOR 50 MG INYECTABLE
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2024
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS VIFOR FRESENIUS MEDICAL CARE RENAL PHARM: AVACOPAN 10MG CAPSULAS DURAS
II.1.2)Main CPV code
33652300 Immunosuppressive agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS VIFOR FRESENIUS MEDICAL CARE RENAL PHARM: AVACOPAN 10MG CAPSULAS DURAS
II.1.5)Estimated total value
Value excluding VAT: 1 660 538.88 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS VIFOR FRESENIUS MEDICAL CARE RENAL PHARM: AVACOPAN 10MG CAPSULAS DURAS
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2024
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
AGENTES ANTINEOPLASICOS INTRAVENOSOS
II.1.2)Main CPV code
33652100 Antineoplastic agents
II.1.3)Type of contract
Supplies
II.1.4)